Edition:
India

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

65.14USD
1:30am IST
Change (% chg)

$-0.12 (-0.18%)
Prev Close
$65.26
Open
$65.55
Day's High
$66.72
Day's Low
$63.10
Volume
315,715
Avg. Vol
382,519
52-wk High
$73.90
52-wk Low
$14.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.36 -0.617
FY 2017 Dec '17 32.33 0.159
Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
FY 2016 Dec '16 2.34 1.395
Sep '16 1.55 -0.369
Jun '16 0.80 -0.432
Mar '16 0.48 -0.212
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 1.83 2.90 0.50 4.00
Quarter Ending Sep-18 5 4.14 9.50 0.50 4.00
Year Ending Dec-18 6 10.74 24.00 2.90 14.75
Year Ending Dec-19 6 22.12 91.10 0.00 16.87
Earnings (per share)
Quarter Ending Jun-18 6 -0.63 -0.59 -0.71 -0.62
Quarter Ending Sep-18 7 -0.63 -0.51 -0.75 -0.61
Year Ending Dec-18 7 -2.58 -2.38 -2.89 -3.01
Year Ending Dec-19 7 -2.92 -1.90 -4.13 -3.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 1,990.69 -- --
EPS (TTM) % -194.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.99 -0.56 99 --
13 Week 21.54 15.62 99 --
26 Week 0.05 -7.55 99 --
52 Week -- -- -- --
YTD -4.74 -16.34 81 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.47%
# of Holders: 161
Total Shares Held: 19,096,292
3 Mo. Net Change: -1,139,411
# New Positions: 74
# Closed Positions: 14
# Increased Positions: 108
# Reduced Positions: 46
# Net Buyers: 62
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.